Register for our free email digests:
Amarin Corp. PLC
www.amarincorp.com
Latest From Amarin Corp. PLC
Novartis And The Medicines Company: Five Things To Worry About
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
Supreme Court Doesn't Bite On Amarin Appeal In Omega-3 Fair Trade Complaint
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Orchard’s Gene Therapy Under Fast-Track Review At EMA
Five Companies To Watch At The Jefferies Conference
Novartis and Roche will present alongside up-and-coming biotechs and microcaps.
.Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Therapeutic Areas
- Cardiovascular
- Alias(es)
- Ethical Holdings
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Ireland
-
Ireland
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Amarin Corp. PLC
- Senior Management
-
John F Thero, Pres. & CEO
Michael W Kalb, SVP, CFO
Craig B Granowitz, MD, PhD, SVP, CMO
Rami Daoud, SVP, Corp. Dev.
Steven Ketchum, PhD, SVP, R&D & CSO
Aaron Berg, SVP, Chief Commercial Officer - Contact Info
-
Amarin Corp. PLC
Phone: (353) 1 6699 020
2 Pembroke House, St. 28-32
Dublin 2,
Ireland
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice